{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:35:03Z","timestamp":1761057303017},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12,24]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n               <jats:p>X-linked agammaglobulinaemia (XLA) is a B cell humoral abnormality arising from mutations in the gene encoding Bruton\u2019s tyrosine kinase (Btk). The phenotype of XLA can be variable, with some individuals having a less severe immunophenotype, although in most cases this cannot be correlated with the Btk mutation or expression of Btk protein. In this study we describe clinical and immunological heterogeneity within the same pedigree. Analysis of the genetic defect identified a missense mutation in the kinase domain of Btk which, unusually, preserved Btk protein expression but at reduced levels, and also considerably diminished autophosphorylation activity. Structural analysis of the effect of this mutation on the kinase domain suggests that this mutation is not an integral part of the ATP or substrate binding domains but may affect the interaction of the kinase domain with its own kinase domain and other substrates. Together, these data may provide an explanation for the variable XLA phenotype.<\/jats:p>","DOI":"10.1046\/j.1365-2249.2000.01230.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:21:27Z","timestamp":1047378087000},"page":"346-350","source":"Crossref","is-referenced-by-count":19,"title":["Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype"],"prefix":"10.1093","volume":"120","author":[{"given":"H B","family":"Gaspar","sequence":"first","affiliation":[{"name":"Molecular Immunology Unit, Institute of Child Health, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Ferrando","sequence":"additional","affiliation":[{"name":"Immunology and Immunodeficiencies Unit and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Caragol","sequence":"additional","affiliation":[{"name":"Immunology and Immunodeficiencies Unit and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Immunology and Immunodeficiencies Unit and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M","family":"Bertran","sequence":"additional","affiliation":[{"name":"Immunology and Immunodeficiencies Unit and"},{"name":"Pneumonology Service, Hospitals Vall d\u2019Hebron, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"De gracia","sequence":"additional","affiliation":[{"name":"Pneumonology Service, Hospitals Vall d\u2019Hebron, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Lester","sequence":"additional","affiliation":[{"name":"Clinical Molecular Genetics Laboratory, Great Ormond Street Hospital NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Kinnon","sequence":"additional","affiliation":[{"name":"Molecular Immunology Unit, Institute of Child Health, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Ashton","sequence":"additional","affiliation":[{"name":"Molecular Immunology Unit, Institute of Child Health, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Espanol","sequence":"additional","affiliation":[{"name":"Immunology and Immunodeficiencies Unit and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"2022011221075694700_b1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","article-title":"Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia","volume":"72","author":"Tsukada","year":"1993","journal-title":"Cell"},{"key":"2022011221075694700_b2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/361226a0","article-title":"The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases","volume":"361","author":"Vetrie","year":"1993","journal-title":"Nature"},{"key":"2022011221075694700_b3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood.V85.2.343.343","article-title":"Tec protein-tyrosine kinase is involved in interleukin-3 signaling pathway","volume":"85","author":"Mano","year":"1995","journal-title":"Blood"},{"key":"2022011221075694700_b4","first-page":"3683","article-title":"BMX, a novel nonreceptor tyrosine kinase gene of the BTK\/ITK\/TEC\/TXK family located in chromosome Xp22.2","volume":"9","author":"Tamagnone","year":"1994","journal-title":"Oncogene"},{"key":"2022011221075694700_b5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1073\/pnas.90.2.669","article-title":"Developmental regulation of a murine T-cell-specific tyrosine kinase gene, Tsk","volume":"90","author":"Heyeck","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011221075694700_b6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/bies.950181009","article-title":"X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease","volume":"18","author":"Mattsson","year":"1996","journal-title":"Bioessays"},{"key":"2022011221075694700_b7","doi-asserted-by":"crossref","first-page":"11037","DOI":"10.1074\/jbc.270.19.11037","article-title":"Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association","volume":"270","author":"Matsuda","year":"1995","journal-title":"J Biol Chem"},{"key":"2022011221075694700_b8","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1084\/jem.180.6.2101","article-title":"IL-5 receptor-mediated tyrosine phosphorylation of SH2\/SH3-containing proteins and activation of Bruton\u2019s tyrosine and Janus 2 kinases","volume":"180","author":"Sato","year":"1994","journal-title":"J Exp Med"},{"key":"2022011221075694700_b9","first-page":"5108","article-title":"Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking","volume":"14","author":"Kawakami","year":"1994","journal-title":"Mol Cell Biol"},{"key":"2022011221075694700_b10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1074-7613(00)80555-5","article-title":"SHIP modulates immune receptor responses by regulating membrane association of Btk","volume":"8","author":"Bolland","year":"1998","journal-title":"Immunity"},{"key":"2022011221075694700_b11","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/emboj\/17.7.1973","article-title":"Btk\/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation","volume":"17","author":"Fluckiger","year":"1998","journal-title":"EMBO J"},{"key":"2022011221075694700_b12","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/emboj\/17.7.1961","article-title":"Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)\/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals","volume":"17","author":"Scharenberg","year":"1998","journal-title":"EMBO J"},{"key":"2022011221075694700_b13","doi-asserted-by":"crossref","first-page":"11526","DOI":"10.1073\/pnas.94.21.11526","article-title":"Phosphorylation of two regulatory tyrosine residues in the activation of Bruton\u2019s tyrosine kinase via alternative receptors","volume":"94","author":"Wahl","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011221075694700_b14","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1126\/science.271.5250.822","article-title":"Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases","volume":"271","author":"Rawlings","year":"1996","journal-title":"Science"},{"key":"2022011221075694700_b15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/nar\/26.1.242","article-title":"BTKbase, mutation database for X-linked agammaglobulinemia (XLA)","volume":"26","author":"Vihinen","year":"1998","journal-title":"Nucl Acids Res"},{"key":"2022011221075694700_b16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/adc.74.6.548","article-title":"X linked agammaglobulinaemia with a \u2018leaky\u2019 phenotype","volume":"74","author":"Jones","year":"1996","journal-title":"Arch Dis Child"},{"key":"2022011221075694700_b17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/blood.V88.2.561.bloodjournal882561","article-title":"Identification of Bruton\u2019s tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan","volume":"88","author":"Hashimoto","year":"1996","journal-title":"Blood"},{"key":"2022011221075694700_b18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0091-6749(97)70176-3","article-title":"Extreme variation in X-linked agammaglobulinemia phenotype in a three-generation family","volume":"100","author":"Kornfeld","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"2022011221075694700_b19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2230.2007.02592.x","article-title":"Bruton\u2019s tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA","volume":"111","author":"Gaspar","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"2022011221075694700_b20","first-page":"595","article-title":"Deficient expression of Bruton\u2019s tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection","volume":"91","author":"Futatani","year":"1998","journal-title":"Blood"},{"key":"2022011221075694700_b21","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/hmg\/3.6.1031-a","article-title":"SSCP at the BTK locus","volume":"3","author":"Vorechovsky","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2022011221075694700_b22","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/hmg\/3.10.1743","article-title":"Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia","volume":"3","author":"Hagemann","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2022011221075694700_b23","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/hmg\/3.10.1751","article-title":"Screening of genomic DNA to identify mutations in the gene for Bruton\u2019s tyrosine kinase","volume":"3","author":"Conley","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2022011221075694700_b24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/00006454-198810000-00012","article-title":"Hypogammaglobulinemia and depressed natural killer cell cytotoxicity in a patient with Pneumocystis carinii infection","volume":"7","author":"Staugas","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"2022011221075694700_b25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-3476(83)80415-6","article-title":"Pneumocystis carinii pneumonitis in patients with hypogammaglobulinemia and intact T cell immunity","volume":"103","author":"Rao","year":"1983","journal-title":"J Pediatr"},{"key":"2022011221075694700_b26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0091-6749(98)70363-X","article-title":"Pneumocystis carinii pneumonia in an infant with X-linked agammaglobulinemia","volume":"101","author":"Alibrahim","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"2022011221075694700_b27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00005792-198505000-00001","article-title":"X-linked agammaglobulinemia: an analysis of 96 patients","volume":"64","author":"Lederman","year":"1985","journal-title":"Med Baltimore"},{"key":"2022011221075694700_b28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0090-1229(89)90021-4","article-title":"Common variable hypogammaglobulinemia, recurrent Pneumocystis carinii pneumonia on intravenous gamma-globulin therapy, and natural killer deficiency","volume":"51","author":"Bonagura","year":"1989","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011221075694700_b29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF03401645","article-title":"A novel mutation (Cys145\u2192Stop) in Bruton\u2019s tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male","volume":"2","author":"Kornfeld","year":"1996","journal-title":"Mol Med"},{"key":"2022011221075694700_b30","doi-asserted-by":"crossref","first-page":"12803","DOI":"10.1073\/pnas.91.26.12803","article-title":"Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease","volume":"91","author":"Vihinen","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011221075694700_b31","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1093\/hmg\/3.10.1899","article-title":"Unique mutations of Bruton\u2019s tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families","volume":"3","author":"Zhu","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2022011221075694700_b32","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1073\/pnas.94.2.604","article-title":"BAP-135, a target for Bruton\u2019s tyrosine kinase in response to B cell receptor engagement","volume":"94","author":"Yang","year":"1997","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2000.01230.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2000.01230.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/120\/2\/346\/42129339\/j.1365-2249.2000.01230.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/120\/2\/346\/42129339\/j.1365-2249.2000.01230.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:47:38Z","timestamp":1676375258000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/120\/2\/346\/6461612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2001,12,24]]},"published-print":{"date-parts":[[2001,12,24]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2249.2000.01230.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,5]]},"published":{"date-parts":[[2000,5]]}}}